Cargando…

Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates

OBJECTIVE: We tested the effects of structured health care for the diabetic foot in one region in Germany aiming to reduce the number of major amputations. RESEARCH DESIGN AND METHODS: In a prospective study we investigated patients with diabetic foot in a structured system of outpatient, in-patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weck, Matthias, Slesaczeck, Torsten, Paetzold, Hartmut, Muench, Dirk, Nanning, Thomas, Gagern, Georg von, Brechow, Andrej, Dietrich, Ulf, Holfert, Mandy, Bornstein, Stefan, Barthel, Andreas, Thomas, Antje, Koehler, Carsta, Hanefeld, Markolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627905/ https://www.ncbi.nlm.nih.gov/pubmed/23497152 http://dx.doi.org/10.1186/1475-2840-12-45

Ejemplares similares

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study
por: Hanefeld, Markolf, et al.
Publicado: (2007)

Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
por: Schindler, Christoph, et al.
Publicado: (2017)

Shifting the Disease Management Paradigm From Glucose: What are the cons?
por: Hanefeld, Markolf, et al.
Publicado: (2009)

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes
por: Hanefeld, Markolf, et al.
Publicado: (2017)

The metabolic vascular syndrome - guide to an individualized treatment
por: Hanefeld, Markolf, et al.
Publicado: (2016)

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
por: Hanefeld, Markolf
Publicado: (2007)

Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
por: Hanefeld, Markolf, et al.
Publicado: (2013)

The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
por: Drzewoski, Józef, et al.
Publicado: (2021)

Is Hyperglycemia a Cardiovascular Risk Factor?
por: Pistrosch, Frank, et al.
Publicado: (2011)

Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
por: Hanefeld, Markolf, et al.
Publicado: (2013)

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study
por: Hanefeld, Markolf, et al.
Publicado: (2011)

A review of glucagon‐like peptide‐1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus
por: Owens, David R., et al.
Publicado: (2017)

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report
por: Haider, Ahmad, et al.
Publicado: (2019)

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL
por: Hanefeld, Markolf, et al.
Publicado: (2017)

Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials
por: Hanefeld, Markolf, et al.
Publicado: (2016)

Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update
por: Hanefeld, Markolf, et al.
Publicado: (2020)

Pain and Reorganization after Amputation: Is Interoceptive Prediction a Key?
por: Weiss, Thomas, et al.
Publicado: (2022)

Cases of Amputation of the Foot
por: Watson,
Publicado: (1868)

Amputation through the Foot
por: Forbes, S. F.
Publicado: (1889)

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers
por: Pistrosch, Frank, et al.
Publicado: (2021)

Thirty Days vs One-Year Complications and Reoperations after Foot Amputation and Below Knee Amputation: A Large Database Study
por: Riepen, Dietrich, et al.
Publicado: (2022)

Treatment of the diabetic foot – to amputate or not?
por: Weledji, Elroy P, et al.
Publicado: (2014)

Distal amputations for the diabetic foot
por: Nather, Aziz, et al.
Publicado: (2013)

Amputation for Traumatic Gangrene of the Foot
por: Simpson, C. A.
Publicado: (1882)

Observations on Amputation
por: Creaser, Thomas
Publicado: (1824)

Sudomotor Testing of Diabetes Polyneuropathy
por: Krieger, Sarah-Maria, et al.
Publicado: (2018)

Diabetic Foot Ulcer: Amputation on Request?
por: Collier, Andrew, et al.
Publicado: (2011)

Annual Foot Exams and Incident Amputation
por: Allen, Latricia, et al.
Publicado: (2020)

Analysis of routine blood markers for predicting amputation/re‐amputation risk in diabetic foot
por: Gülcü, Anıl, et al.
Publicado: (2020)

Amputation-specific and generic correlates of participation among Veterans with lower limb amputation
por: Erbes, Christopher R., et al.
Publicado: (2022)

An observational study of learning effects of peer‐assisted learning tests in COVID‐19 pandemic times
por: Holfert, Jonathan, et al.
Publicado: (2021)

“You can be a behaviorist and still talk about the mind – as long as you don't put it into a person's head”: An interview with Howard Rachlin
por: Simon, Carsta
Publicado: (2022)

Independent risk factors for amputation in diabetic foot
por: Shojaiefard, Abolfazl, et al.
Publicado: (2008)

Predictors for Amputation in Patients with Diabetic Foot Wound
por: Kim, Se-Young, et al.
Publicado: (2018)

Account of an Amputation Performed with Success in the Middle of the Foot
por: Turner, T.
Publicado: (1788)

Risk factors affecting amputation in diabetic foot
por: Lee, Jun Ho, et al.
Publicado: (2020)

Ray Amputation in a Traumatic Diabetic Foot
por: Lawrence, Rebecca, et al.
Publicado: (2022)

Risk assessment of amputation in patients with diabetic foot
por: Tanasescu, Denisa, et al.
Publicado: (2022)

Risk factors that predict major amputations and amputation time intervals for hospitalised diabetic patients with foot complications
por: Chou, Yu‐Yu, et al.
Publicado: (2021)

Comparative Efficacy of Conservative Surgery vs Minor Amputation for Diabetic Foot Osteomyelitis
por: Schöni, Madlaina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lvc6v9f041vdtoqgipus50l33h